IT201600083753A1 - Immunosage for the identification of antibodies against the Polioma BK virus (BKPyV) through the use of synthetic peptides. - Google Patents

Immunosage for the identification of antibodies against the Polioma BK virus (BKPyV) through the use of synthetic peptides.

Info

Publication number
IT201600083753A1
IT201600083753A1 IT102016000083753A IT201600083753A IT201600083753A1 IT 201600083753 A1 IT201600083753 A1 IT 201600083753A1 IT 102016000083753 A IT102016000083753 A IT 102016000083753A IT 201600083753 A IT201600083753 A IT 201600083753A IT 201600083753 A1 IT201600083753 A1 IT 201600083753A1
Authority
IT
Italy
Prior art keywords
immunosage
bkpyv
polioma
virus
identification
Prior art date
Application number
IT102016000083753A
Other languages
Italian (it)
Inventor
Fernanda Martini
Mauro Tognon
Elisa Mazzoni
Ilaria Bononi
Silvia Pietrobon
Original Assignee
Univ Degli Studi Di Ferrara
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Degli Studi Di Ferrara filed Critical Univ Degli Studi Di Ferrara
Priority to IT102016000083753A priority Critical patent/IT201600083753A1/en
Publication of IT201600083753A1 publication Critical patent/IT201600083753A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
    • C12N2710/22022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
IT102016000083753A 2016-08-09 2016-08-09 Immunosage for the identification of antibodies against the Polioma BK virus (BKPyV) through the use of synthetic peptides. IT201600083753A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT102016000083753A IT201600083753A1 (en) 2016-08-09 2016-08-09 Immunosage for the identification of antibodies against the Polioma BK virus (BKPyV) through the use of synthetic peptides.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102016000083753A IT201600083753A1 (en) 2016-08-09 2016-08-09 Immunosage for the identification of antibodies against the Polioma BK virus (BKPyV) through the use of synthetic peptides.

Publications (1)

Publication Number Publication Date
IT201600083753A1 true IT201600083753A1 (en) 2018-02-09

Family

ID=58606303

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102016000083753A IT201600083753A1 (en) 2016-08-09 2016-08-09 Immunosage for the identification of antibodies against the Polioma BK virus (BKPyV) through the use of synthetic peptides.

Country Status (1)

Country Link
IT (1) IT201600083753A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011098484A1 (en) * 2010-02-09 2011-08-18 Academisch Ziekenhuis Leiden Also Acting Under The Name "Leiden University Medical Center" (Lumc) Trichodysplasia spinulosa- associated polyomavirus (tsv)
WO2015042254A1 (en) * 2013-09-18 2015-03-26 The Johns Hopkins University Bk virus serology assessment of progressive multifocal leukoencephalopathy (pml) risk

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011098484A1 (en) * 2010-02-09 2011-08-18 Academisch Ziekenhuis Leiden Also Acting Under The Name "Leiden University Medical Center" (Lumc) Trichodysplasia spinulosa- associated polyomavirus (tsv)
WO2015042254A1 (en) * 2013-09-18 2015-03-26 The Johns Hopkins University Bk virus serology assessment of progressive multifocal leukoencephalopathy (pml) risk

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ADRIAN EGLI ET AL: "Polyomavirus BK after Kidney Transplantation - Role of Molecular and Immunologic Markers", TRANSPLANTATION, vol. 3, 1 January 2009 (2009-01-01), pages 85 - 102, XP055160594 *
ALFREDO CORALLINI ET AL: "Specific antibodies reacting with simian virus 40 capsid protein mimotopes in serum samples from healthy blood donors", HUMAN IMMUNOLOGY, NEW YORK, NY, US, vol. 73, no. 5, 10 February 2012 (2012-02-10), pages 502 - 510, XP028417855, ISSN: 0198-8859, [retrieved on 20120221], DOI: 10.1016/J.HUMIMM.2012.02.009 *
DALIANIS TINA ET AL: "Human polyomaviruses in disease and cancer", VIROLOGY, ELSEVIER, AMSTERDAM, NL, vol. 437, no. 2, 26 January 2013 (2013-01-26), pages 63 - 72, XP028978696, ISSN: 0042-6822, DOI: 10.1016/J.VIROL.2012.12.015 *
DATABASE Geneseq [online] GeneSeq; 2 October 2008 (2008-10-02), SCHOLLER J; PEDERSEN H; BRIX L: "BK virus antigen class II peptide SEQ ID NO:27860 (WO2008/116468)", XP002770727, accession no. AWC35799 Database accession no. AWC35799 *
DATABASE Geneseq [online] GeneSeq; 2 October 2008 (2008-10-02), SCHOLLER J; PEDERSEN H; BRIX L: "BK virus antigen class II peptide SEQ ID NO:27918 (WO2008/116468)", XP002770728, accession no. AWC35857 Database accession no. AWC35857 *
SILVIA PIETROBON ET AL: "Specific IgG Antibodies React to Mimotopes of BK Polyomavirus, a Small DNA Tumor Virus, in Healthy Adult Sera", FRONTIERS IN IMMUNOLOGY, vol. 8, 6 March 2017 (2017-03-06), XP055377879, DOI: 10.3389/fimmu.2017.00236 *

Similar Documents

Publication Publication Date Title
CL2017001408A1 (en) Anti-cd79b antibodies and methods of use
CL2019003114A1 (en) Anti-tau antibodies and methods of use (divisional application 201703063)
EP3387600A4 (en) Integrated system of search, commerce and analytics engines supported by beacons
CL2017000590A1 (en) Anti-cll-1 and immunoconjugate antibodies
CL2017001610A1 (en) Human antibodies to influenza hemagglutinin
DK3402820T3 (en) HUMANIZED, MUSEUM OR CHEMICAL ANTI-CD47 MONOCLONAL ANTIBODIES
EA202092435A3 (en) MONOCLONAL ANTIBODIES AGAINST BCMA
BR112019012343A2 (en) il-11ra antibodies
CR20160362A (en) ANTI-JAGGED1 ANTIBODIES AND METHODS OF USE
EA201791029A1 (en) ANTIBODIES AGAINST INTERLEUKIN-33 AND THEIR APPLICATION
BR112017009175A2 (en) adsorbent materials and methods of use
EA201891339A1 (en) AQUEOUS PHARMACEUTICAL PREPARATION THAT CONTAINS ANTIBODY TO PD-L1 AVELUMAB
CY1124521T1 (en) ANTI-CD19 ANTIBODY PREPARATIONS
CL2018001139A1 (en) Anti-htra1 antibodies and methods of use thereof.
DK3606961T3 (en) GARP-TGF-BETA ANTIBODIES
CL2021000426A1 (en) Inhibitors of the keap1-nrf2 protein-protein interaction.
FR3046436B1 (en) ELECTROSTATIC CONVERTER.
DK3464331T3 (en) STABILIZED PREFUSION RSV F PROTEINS
EP3384035A4 (en) Assays for the detection of aav neutralizing antibodies
CL2020002333A1 (en) Anti-klk5 antibodies and methods of use.
BR112019023123A2 (en) PULTRUDED ARTICLE, USE OF PULTRUDED ARTICLE, METHOD FOR FORMING THE ARTICLE
DK3484921T3 (en) Anti-IL-22R antibodies
BR112016029935A2 (en) anti-brdu antibodies, complex, pharmaceutical formulation and antibody use?
EA201891717A1 (en) PREPARATIONS OF MULTI-GENOMIC RETROVIRAL VECTORS AND METHODS AND SYSTEMS FOR THEIR RECEPTION AND APPLICATION
EP3452504A4 (en) Dna monoclonal antibodies targeting influenza virus